Geneos Wealth Management’s MediWound MDWD Stock Holding History

Geneos Wealth Management’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.16K	Hold	215	–	–	﹤0.01%	2268
2026 Q1	$3.46K	Hold	215	–	–	﹤0.01%	2228
2025 Q4	$3.97K	Hold	215	–	–	﹤0.01%	2203
2025 Q3	$3.87K	Hold	215	–	–	﹤0.01%	2204
2025 Q2	$4.17K	Hold	215	–	–	﹤0.01%	2623
2025 Q1	$3.34K	Hold	215	–	–	﹤0.01%	2634
2024 Q4	$3.83K	Buy	+215	New	+$3.71K	﹤0.01%	2417
2022 Q4	–	Sell	-214	Closed	-$2K	–	2064
2022 Q3	$2K	Hold	214	–	–	﹤0.01%	1847
2022 Q2	$2K	Hold	214	–	–	﹤0.01%	2400
2022 Q1	$2K	Hold	214	–	–	﹤0.01%	2553
2021 Q4	$3K	Hold	214	–	–	﹤0.01%	2529
2021 Q3	$5K	Hold	214	–	–	﹤0.01%	2454
2021 Q2	$5K	Sell	214 -215	-50%	-$6.64K	﹤0.01%	2451
2021 Q1	$13K	Hold	429	–	–	﹤0.01%	2263
2020 Q4	$14K	Buy	429 +215	+100%	+$5.58K	﹤0.01%	2081
2020 Q3	$5K	Buy	+214	New	+$5.47K	﹤0.01%	2183

Other funds holding MDWD

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Geneos Wealth Management's MDWD Position: Q2 2026 in Review

Geneos Wealth Management held its MediWound (MDWD) position steady in Q2 2026 at 215 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2268.

Geneos Wealth Management first reported a position in MDWD in Q3 2020 and has held it in 16 quarters since. The position peaked at $14K in Q4 2020. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

Geneos Wealth Management held 215 shares of MediWound worth $3.16K as of Q2 2026.
Geneos Wealth Management left its MediWound share count unchanged in Q2 2026.
MediWound made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2268 holding.
Geneos Wealth Management first reported a position in MediWound in Q3 2020 and has held it in 16 quarters since.
Geneos Wealth Management's MediWound position peaked at $14K in Q4 2020.
79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.